← Open Payments lookup

JASON CROWL: Open Payments

NPI 1518520923 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$923 in 40 payments from 13 companies in 2025. Trend: 2023 $545 · 2024 $1,193 · 2025 $923

Food & beverage: $855Education: $69
CompanyPaymentsAmount
Novo Nordisk Inc9$219
Astellas Pharma US Inc5$135
AstraZeneca Pharmaceuticals LP7$135
ABBVIE INC.3$82
Otsuka America Pharmaceutical, Inc.3$66
Lilly USA, LLC2$62
PFIZER INC.3$55
Phathom Pharmaceuticals, Inc.2$45
Amgen Inc.2$42
Bayer Healthcare Pharmaceuticals Inc.1$24

Products named: Ozempic, VRAYLAR, Veozah, REXULTI, MOUNJARO, FARXIGA, VOQUEZNA, FASENRA.

Industry payments across MD — which companies pay providers there.